Xsolla Showcases Industry Insights and Regional Commitment at Digital Dragons 2026
14.5.2026 15:00:00 CEST | Business Wire | Press Release
Xsolla, a global video game commerce company that helps developers launch, grow, and monetize their games, today announced its participation in Digital Dragons 2026, one of Europe’s premier game industry conferences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260514302984/en/
Graphic: Xsolla
As the video game industry continues to evolve, early indicators from Q1 2026 point to sustained momentum across key segments. Xsolla’s presence at Digital Dragons will reflect on several emerging themes shaping the market, including:
- The ongoing strength of live-service and hybrid monetization models
- Increased adoption of direct-to-consumer (D2C) strategies by developers and publishers
- Growing demand for localized payment solutions to support global player bases
- A heightened focus on player engagement, retention, and community-building tools
These insights underscore the industry’s shift toward long-term player relationships and diversified revenue strategies.
Poland continues to play a significant role in the global video game industry, with recent projections valuing the market at approximately €1.3 billion annually through 2026. Notably, more than 95% of the industry’s revenue comes from exports, underscoring the international reach and impact of Polish game developers.
"Central and Eastern Europe has a thriving games industry community and remains a region with tremendous growth potential,” said Błażej Krakowiak, Business Development/Developer Relations Lead, CEE at Xsolla. “Digital Dragons sits at its heart. Year after year, this conference brings together an incredible concentration of creative talent and business opportunity. We keep coming back because the developers and studios here are building something remarkable, and Xsolla supports them with all the things needed to succeed globally."
At Digital Dragons, Xsolla will also highlight recent updates across its suite of products and services, including enhancements to its Web Shop, expanded payment options, and publishing suite offerings. Xsolla is committed to building the tools and services that help the video game industry grow, enabling game developers to launch, grow, and win. Together, these solutions are designed to help developers simplify global distribution, optimize monetization, and create seamless player experiences.
“Digital Dragons is a key moment for the industry to come together, share ideas, and explore new opportunities,” said Berkley Egenes, Chief Marketing & Growth Officer at Xsolla. “We’re excited to engage with developers, share how we have been building all the things for the industry, and continue supporting the growth of the global games ecosystem.”
Attendees are invited to connect with Xsolla during the event and attend the upcoming session for insights into the latest industry trends and innovations.
Błażej Krakowiak, Business Development/Developer Relations Lead, CEE at Xsolla, will host a 45-minute speaking session on Monday, 18th May at 11:00 AM CEST titled, ‘Your Game Is Invisible: Surviving the Discoverability Collapse’, which will examine different perspectives and give developers proven tactics to connect with audiences at every step from monetization to long-term support.
While Anatoly Strutinsky, SVP Government & Industry Relations, EMEA at Xsolla will participate as a speaker on a panel titled, ‘State of the Industry 2026: Service Providers The New Production Ecosystem’ on Tuesday 19th May at 10:00 AM - 11:00 AM CEST alongside Coleman Dan of Iron Galaxy; Viki Freeman of Airship; Siemion Branzburg of Transperfect; and Charlie Bowers of Service.com, exploring the role of service providers and how studios can effectively integrate external teams into production pipelines without losing control over quality and IP.
Xsolla remains committed to bringing the global game development community together and is proud to spotlight five studios from Azerbaijan that will showcase their games at Digital Dragons 2026. Selected through an open call and competitive review process conducted in partnership with the IDDA, the chosen studios, DarkNight Studio, Cool Bears Studio, ExTerra Studio, PixelNodes Studio, and Untitle Game Studio, were recognized for their creative vision, project quality, and potential to make an impact on the international stage. This initiative reflects Xsolla's ongoing commitment to connecting game developers with opportunities across geographies, and each selected studio will receive dedicated pitch mentoring, conference preparation support, and access to Digital Dragons' networking and meeting systems ahead of their debut in Kraków.
For more information about Xsolla’s presence at Digital Dragons 2026, please visit: xsolla.pro/Digital-Dragons
About Xsolla
Xsolla is a global commerce company that builds and provides all the things developers need to launch, grow, and monetize video games. Headquartered in Los Angeles, California, the company supports studios of every size, from indie to AAA, with solutions across direct-to-consumer commerce, intelligent payments, entertainment-based IP, and player engagement products. Xsolla helps developers fund, distribute, market, and monetize their games at scale. Trusted by more than 60% of the top 100 highest-grossing games, Xsolla operates as the merchant of record across 200+ geographies with access to over 1,000+ local payment methods worldwide. Grounded in a deep belief in the future of gaming, Xsolla is resolute in bringing opportunities together and unlocking growth for creators everywhere.
For more information, visit xsolla.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260514302984/en/
Contacts
Media Contact
Derrick Stembridge
Vice President of Global Public Relations, Xsolla
d.stembridge@xsolla.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone15.6.2026 06:05:00 CEST | Press Release
Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/ Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk. Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making. “Black Recon
OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release
OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202612.6.2026 23:31:00 CEST | Press Release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom